Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers

BACKGROUND: The application of genomic technologies to patient tumor samples identified groups of signaling pathways which acquire activating mutations. Some cancers are dependent on these mutations and the aberrant proteins resulting from these mutations can be targeted by novel drugs which can era...

Descripción completa

Detalles Bibliográficos
Autores principales: Milewska, Malgorzata, Cremona, Mattia, Morgan, Clare, O’Shea, John, Carr, Aoife, Vellanki, Sri HariKrishna, Hopkins, Ann M., Toomey, Sinead, Madden, Stephen F., Hennessy, Bryan T., Eustace, Alex J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784557/
https://www.ncbi.nlm.nih.gov/pubmed/29383036
http://dx.doi.org/10.1177/1758834017746040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784557/
https://www.ncbi.nlm.nih.gov/pubmed/29383036
http://dx.doi.org/10.1177/1758834017746040

Ejemplares similares